Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
438.00    0.00 (0.00%)
Bid:
420.00
Ask:
510.00
Spread: 90.00 (21.429%)
Market Cap: £11.02b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Disposal of Style Conferences

29 Nov 2005 07:03

Rentokil Initial PLC29 November 2005 For immediate release Rentokil Initial PLC29 November 2005 Rentokil Initial - Disposal of Style Conferences Rentokil Initial plc ("Rentokil" or the "Company") announces that it has enteredinto arrangements with Alternative Hotel Group, a group of investors led byRichard Balfour-Lynn and other MWB directors acting in their private capacitypartnering with Bank of Scotland, pursuant to which it expects to sell theInitial Style Conferences business ("Style Conferences" or the "Business") for atotal consideration of £325 million on a debt free cash free basis, to be paidin cash at completion. It is Rentokil's intention to apply the proceeds againstcurrent indebtedness and the transaction is expected to close within two weeks. Style Conferences is the market leader in the provision of training andconferencing venues in the UK and owns the freehold of 21 of the 29 centres thatit operates. It was acquired as part of the BET group of businesses in 1996 andhas always been operated on a standalone basis. For the twelve months ended 31December 2004, the Business generated operating profit of £25.3 million andprofit before tax of £19.7million on turnover of £91.1 million. As at 31December 2004 Style Conferences had net assets of £128.9 million and grossassets of £165.0 million. Doug Flynn, Chief Executive of Rentokil Initial, said today: "We decided to sell Style Conferences because its operating characteristics aresubstantially different from other businesses in the Company, and because webelieve that there are other owners for whom the business would be a better fit. This transaction is a good outcome for our shareholders and has been achieved inline with the timetable we set earlier in the year. It is another step forwardtowards our aim of creating a clearer strategic focus by concentrating upon thedevelopment of those businesses which can add most value for our shareholders." Enquiries: Rentokil Initial plc +44 (0) 1342 833022 Mark Boyle, Group Strategy & Development DirectorCharles Grimaldi, Corporate Affairs Director Greenhill & Co. International LLP +44 (0) 20 7440 0400 Simon BorrowsEdward Wakefield Brunswick Group LLP +44 (0) 20 7404 5959 John SunnucksGill Ackers NOTES FOR EDITORS: Style Conferences' turnover, operating profit and net assets are derived fromthe segmental analysis in Rentokil's annual accounts as at 31 December 2004.Style Conferences' profit before tax and gross assets are derived from InitialStyle Conferences Limited statutory accounts as at 31 December 2004. Greenhill & Co. International LLP ("Greenhill & Co."), which is regulated by theFinancial Services Authority, is acting for Rentokil Initial plc in connectionwith the disposal of Style Conferences and for no one else and will not beresponsible to anyone other than Rentokil for providing the protections affordedto customers of Greenhill & Co. nor for providing advice in relation to thispotential transaction. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.